Editas Medicine, Inc.
EDIT
$2.76
-$0.0708-2.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.44% | -51.22% | -54.74% | -7.94% | 6.00% |
| Total Depreciation and Amortization | 15.87% | 6.54% | -4.21% | -4.55% | -7.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.57% | 19.92% | 5.91% | -15.00% | -24.50% |
| Change in Net Operating Assets | -31.88% | 621.15% | 316.44% | -59.70% | -46.90% |
| Cash from Operations | -22.31% | -42.34% | -59.09% | -19.41% | 0.07% |
| Capital Expenditure | 48.27% | -48.82% | -87.03% | -137.69% | -56.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,437.47% | 953.36% | 17,204.86% | 326.09% | -86.19% |
| Cash from Investing | 2,859.94% | 803.39% | 4,445.91% | 306.20% | -92.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 786.77% | -98.29% | -99.34% | -99.13% | -99.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,881.32% | -53.99% | -52.54% | -99.13% | -99.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.39% | 216.17% | 144.15% | 110.37% | -404.14% |